BridgeMD
Tests treatment safety and results for Diabetes Mellitus, Type 2
Official title Efficacy and Safety of Sanggua Tablets in the Treatment of Patients With Impaired Glucose Tolerance and Mild Type 2 Diabetes
ClinicalTrials.gov ID: NCT06964620
What this study is testing
What is Sanggua tablets?
Sanggua tablets is an investigational medicine, given as an once-daily pill taken by mouth, being studied as a potential treatment for diabetes mellitus, type 2.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Type 2 diabetes mellitus (T2DM) and impaired glucose tolerance (IGT) are growing public health challenges. Early intervention in mild T2DM and IGT is essential to prevent disease progression and severe complications.
- Phase 1: an early, usually small safety study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Patients aged 18-70 with impaired glucose tolerance (IGT).
- Patients aged 18-70 diagnosed with type 2 diabetes mellitus (T2DM) deemed by the clinician not requiring pharmacological intervention.
- Glycated hemoglobin (HbA1c) levels between 5.6% and 7.5%.
- Voluntarily sign an informed consent form before the commencement of trial-related activities, understand the procedures and methods of the trial...
You likely can't join if
- Type 1 diabetes mellitus.
- Known allergies to Sang Gua tablets or any of its components.
- Use of hypoglycemic or lipid-lowering drugs within the last three months.
- Presence of severe primary or secondary respiratory, cardiovascular, hepatic, or renal diseases, rheumatic connective tissue diseases, or...
- Uncontrolled or unstable conditions exacerbated by infections, severe electrolyte imbalances, or other factors.
- Patients with primary or secondary kidney diseases, hypertension, heart failure, acidosis, or urinary tract infections causing increased urinary...
See the full eligibility criteria
- Patients aged 18-70 with impaired glucose tolerance (IGT).
- Patients aged 18-70 diagnosed with type 2 diabetes mellitus (T2DM) deemed by the clinician not requiring pharmacological intervention.
- Glycated hemoglobin (HbA1c) levels between 5.6% and 7.5%.
- Voluntarily sign an informed consent form before the commencement of trial-related activities, understand the procedures and methods of the trial, and are willing and able to strictly adhere to the clinical trial...
- Type 1 diabetes mellitus.
- Known allergies to Sang Gua tablets or any of its components.
- Use of hypoglycemic or lipid-lowering drugs within the last three months.
- Presence of severe primary or secondary respiratory, cardiovascular, hepatic, or renal diseases, rheumatic connective tissue diseases, or hematological disorders.
- Uncontrolled or unstable conditions exacerbated by infections, severe electrolyte imbalances, or other factors.
- Patients with primary or secondary kidney diseases, hypertension, heart failure, acidosis, or urinary tract infections causing increased urinary protein, excepted.
- Patients with psychiatric disorders.
- Pregnant or planning to become pregnant women, or nursing mothers.
- Patients requiring long-term steroid therapy.
- Patients with poorly controlled hypertension or secondary hypertension.
- Patients who have participated in other clinical trials within the past three months.
- Patients deemed by the investigator as unsuitable for this clinical trial due to potential interference with trial results, impediments to full participation in the study, medical history, disease evidence, abnormal...
The study team makes the final eligibility decision.
Where it's taking place
- Wuhan, Hubei, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhan, Hubei, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.